Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
118337894 | 11833789 | 4 | F | 2015 | 20160719 | 20151214 | 20160727 | EXP | CA-SYMPLMED PHARMACEUTICALS-2015SYMPLMED000098 | SYMPLMED PHARMACEUTICALS | 0.00 | Y | 0.00000 | 20160727 | OT | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
118337894 | 11833789 | 1 | PS | Coversyl | PERINDOPRIL | 1 | Unknown | UNK | U | U | UNKNOWN | 20184 | TABLET | ||||||
118337894 | 11833789 | 2 | SS | AVAPRO | IRBESARTAN | 1 | Oral | 150 MG, QD | U | U | UNKNOWN | 0 | 150 | MG | |||||
118337894 | 11833789 | 3 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Subcutaneous | 50 ?G, TID | U | U | UNKNOWN | 0 | 50 | UG | |||||
118337894 | 11833789 | 4 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, UNK | U | U | UNKNOWN | 0 | 30 | MG | |||||
118337894 | 11833789 | 5 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Intramuscular | 40 MG, UNK | U | U | UNKNOWN | 0 | 40 | MG | |||||
118337894 | 11833789 | 6 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Subcutaneous | 50 ?G, BID | U | U | UNKNOWN | 0 | 50 | UG | |||||
118337894 | 11833789 | 7 | C | ACEBUTOLOL HYDROCHLORIDE. | ACEBUTOLOL HYDROCHLORIDE | 1 | UNK | U | UNKNOWN | 0 | |||||||||
118337894 | 11833789 | 8 | C | ACETYLSALICYLIC ACID | ASPIRIN | 1 | UNK | U | UNKNOWN | 0 | |||||||||
118337894 | 11833789 | 9 | C | CALCIUM | CALCIUM | 1 | UNK | U | UNKNOWN | 0 | |||||||||
118337894 | 11833789 | 10 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | UNK | U | UNKNOWN | 0 | |||||||||
118337894 | 11833789 | 11 | C | THIAMAZOLE | METHIMAZOLE | 1 | UNK | U | UNKNOWN | 0 | |||||||||
118337894 | 11833789 | 12 | C | METFORMIN HYDROCHLORIDE. | METFORMIN HYDROCHLORIDE | 1 | U | UNKNOWN | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
118337894 | 11833789 | 1 | Product used for unknown indication |
118337894 | 11833789 | 2 | Product used for unknown indication |
118337894 | 11833789 | 3 | Pituitary tumour benign |
118337894 | 11833789 | 7 | Product used for unknown indication |
118337894 | 11833789 | 8 | Product used for unknown indication |
118337894 | 11833789 | 9 | Product used for unknown indication |
118337894 | 11833789 | 10 | Product used for unknown indication |
118337894 | 11833789 | 11 | Product used for unknown indication |
118337894 | 11833789 | 12 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
118337894 | 11833789 | OT |
118337894 | 11833789 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
118337894 | 11833789 | Blood pressure diastolic decreased | |
118337894 | 11833789 | Blood pressure systolic increased | |
118337894 | 11833789 | Body temperature decreased | |
118337894 | 11833789 | Cough | |
118337894 | 11833789 | Diarrhoea | |
118337894 | 11833789 | Dizziness | |
118337894 | 11833789 | Erythema | |
118337894 | 11833789 | Fatigue | |
118337894 | 11833789 | Feeling hot | |
118337894 | 11833789 | Foot deformity | |
118337894 | 11833789 | Injection site erythema | |
118337894 | 11833789 | Labyrinthitis | |
118337894 | 11833789 | Oedema peripheral | |
118337894 | 11833789 | Osteoarthritis | |
118337894 | 11833789 | Skin sensitisation | |
118337894 | 11833789 | Sputum discoloured |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |